The cost of a new randomized trial to evaluate the vaccine’s ability to prevent disease could run into tens of millions of ...

“Markets are now factoring in both a Trump and a Fed ‘put,’” UBS wrote, referring to the belief that both policymakers and ...

Investing.com -- Democratic Senator Elizabeth Warren has requested information from the U.S. Securities regulator regarding ...

Investing.com -- Yardeni Research says its long-standing “Roaring 2020s” scenario could be regaining momentum after recent ...

P&G faced a tougher-than-expected recent quarter due to a global economic slowdown, retailers cutting back on inventory, and ...

Investing.com -- HSBC said investors should focus on high-quality U.S. industrial stocks with limited exposure to tariffs and ...

Despite the policy risks, AbbVie delivered a strong first quarter, posting adjusted earnings per share of $2.46, $0.10 above ...

Investing.com -- KeyBanc Capital Markets has upgraded Lowe’s (NYSE: LOW) and Williams-Sonoma (NYSE: WSM) to Overweight from ...

Investing.com -- With Canada’s federal election looming on April 28, voters and markets are scrutinizing campaign platforms ...

Investing.com -- UBS upgraded Philip Morris International (NYSE: PM) to Neutral from Sell on a stronger-than-expected ...

Investing.com -- AbbVie (NYSE: ABBV) shares climbed over 3% in premarket trading Friday after the drugmaker lifted its ...

Investing.com -- Mizuho Securities upgraded agricultural sciences company FMC Corp (NYSE: FMC) to Outperform from Neutral, ...